Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Finasteride negatively affects fish reproduction and gonadal development.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Topical 5α-reductase inhibitor helps counteract hair loss and stabilize it.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.